Thyrotoxicosis with pegylated interferon alfa-2b.
BACKGROUND: Despite adequate surgery, a diagnosis of stage III melanoma carries a high risk of relapse, and hence mortality. Interferon alfa is the only treatment that has currently been shown to alter the natural history of the disease, delaying relapse-free survival, particularly in patients with...
| المؤلفون الرئيسيون: | , , |
|---|---|
| التنسيق: | Journal article |
| اللغة: | English |
| منشور في: |
2010
|